Michelle Bush
Family · Locust Grove, GANPI 1154450484
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $703 and has fallen 88.7% since, to $79 in 2025.
Across 79 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$214
- Lilly USA, LLC$153
- Otsuka America Pharmaceutical, Inc.$127
- Boehringer Ingelheim$118
- Biohaven Pharmaceutical Holding Company Ltd.$91
- AstraZeneca$82
- plus $594 from 13 others
What the payments were for
- Food & beverage$1,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $214 |
| Lilly USA, LLC | 12 | $153 |
| Otsuka America Pharmaceutical, Inc. | 1 | $127 |
| Boehringer Ingelheim | 8 | $118 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $91 |
| AstraZeneca | 6 | $82 |
| Coloplast | 1 | $79 |
| GSK | 5 | $77 |
| Astellas Pharma US Inc | 6 | $77 |
| Biohaven Pharmaceuticals, Inc. | 3 | $63 |
| Novo Nordisk | 4 | $61 |
| AbbVie | 4 | $54 |
| Merck | 3 | $44 |
| Pfizer | 2 | $38 |
| Amarin Pharma, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Novartis | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,378 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 14 | $64 |
Paid to pharmacies, not to this prescriber.
Other family in Locust Grove
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.